Navigation Links
Egenix, Inc. Appoints Dr. Daniel Petrylak Chairman of Scientific Advisory Board
Date:4/8/2008

MILLBROOK, N.Y., April 8, 2008 /PRNewswire/ -- Donald C. Fresne, Chairman and CEO, Egenix, Inc., announced the appointment of Daniel Petrylak, MD as Chairman of the company's scientific advisory board. Dr. Petrylak is currently Associate Professor of Medicine at Columbia University Medical Center where he is Director of Genitourinary Oncology, Division of Medical Oncology. He is the co-author of numerous peer reviewed scientific papers and is a national leader in the treatment of cancers of prostate, kidney, and bladder. Dr. Petrylak stated, "I enthusiastically look forward to working with the Egenix team. I believe the company's initiatives for development of targeted translation inhibitors will reach the clinic in a timely fashion and provide unique benefits for patients with cancer."

About Egenix, Inc.

Based in Millbrook, New York, Egenix, Inc. is a privately held biotechnology company responding to the demand for more effective cancer therapies. Egenix is developing small molecule inhibitors of translation initiation, a new paradigm in target-specific, non-cytotoxic anti-cancer therapy, and the use of translation initiation-specific biomarkers to assess tumor sensitivity to anti-cancer therapy with this novel class of anti-cancer drugs.


'/>"/>
SOURCE Egenix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
2. Observant LLC Appoints Two New Directors to the Senior Management Team
3. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
4. Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors
5. IDM Pharma Appoints Gregory J. Tibbitts to Board of Directors
6. Caliper Life Sciences Appoints Peter F. McAree Senior Vice President and Chief Financial Officer
7. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
8. Touch Bionics appoints Head of Clinical Advocacy
9. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
10. Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer
11. NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... PA (PRWEB) June 18, 2013 Demanding ... Ball Lenses engineered of synthetic Sapphire and Glass Ball ... sizes from Swiss Jewel Company , of Philadelphia ... by expanding and collimating the light beams without the ... optical clarity and natural durability (9 mohs) make it ...
(Date:6/18/2013)... , June 18, 2013 ... the release of the HELM biomolecular representation standard ... source MIT licence. HELM (Hierarchical Editing ... wide range of biomolecules (e.g. proteins, nucleotides, antibody ... small-molecule and sequence-based informatics methodologies impractical or unusable. ...
(Date:6/18/2013)... , June 18, 2013 Mapi ... (APIs), generic and innovative intermediates, and finished dosage forms based ... has been granted a United States ... Europe for the oral treatment of ... is titled Intermediate Compounds and Processes for the Preparation ...
(Date:6/18/2013)... THE WOODLANDS, Texas , June 18, 2013 ... LXRX ), a biopharmaceutical company focused on ... that John Northcott has joined the ... strategy, and operations. Mr. Northcott brings extensive commercial ... on-market commercialization across a variety of therapeutic areas. ...
Breaking Biology Technology:Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
... applaud Senator Ted Kanavas for his desire to align best ... to see the senator refer to the Sarbanes-Oxley Act of ... at this concept a little closer. President Bush signed Sarbox ... corporate accounting scandals, most notably Enron and WorldCom. , ,Sarbox ...
... in the field and navigating at the helm of several ... (which is located in Woodridge, Ill. across from Argonne ... advance his drug discovery company. , ,Following a six-month ... the next few weeks with financial adviser Legg Mason ...
... with Congresswomen Tammy Baldwin at her Madison office about ... for technology development, as well as how we can ... best known for her unwavering commitment to farmers, senior ... is emerging as a leader in the Wisconsin technology ...
Cached Biology Technology:My View - State Government Needs Integrity To Build Investor Confidence 2Advanced Life Sciences to Hit the Road For $30 Million in Funding 2Advanced Life Sciences to Hit the Road For $30 Million in Funding 3Advanced Life Sciences to Hit the Road For $30 Million in Funding 4WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 2WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 3WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 4WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 5WTN Interview with Congresswoman Tammy Baldwin: Facilitating technology growth and regional economic development is a priority 6
(Date:6/17/2013)... BOSTON , June 17, 2013 ... prolific, the need to secure them grows exponentially, ... the latest report from Heavy Reading Insider ... from Heavy Reading ( www.heavyreading.com ). ... Smartphones examines the market for biometric authentication on ...
(Date:6/17/2013)... The AGA Research Foundation and Horizon Pharma further ... gastroenterology with the 2013 AGA-Horizon Pharma Fellow Abstract Prizes ... "In its third year, this competition continues to grow ... promising careers in basic and clinical research," said Nicholas ... Foundation. "We are extremely proud of all that these ...
(Date:6/17/2013)... French . A ... Alzheimer,s disease can be reversed with treatment. The study by ... Neuro, at McGill University and at Universit de Montral found ... brain of mice with advanced Alzheimer,s disease (AD) recovers memory ... of Neuroinflammation in May, also suggest an underlying mechanism ...
Breaking Biology News(10 mins):Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3Horizon Pharma Abstract Prizes recognize promising fellows and students 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2
... cancer drug asparaginase fails to help cure some children ... certain cells in the bone marrow counteract the effect ... Children's Research Hospital. , The researchers showed that ... niche for leukemic cells by releasing large amounts of ...
... Using a biochemical version of a computer chip, a team ... related to the mating habits of yeast cells. ... Publication of the journal Nature, shed new light on the ... from the environment through a process called signal transduction. That ...
... Harvard School of Public Health (HSPH) finds that polio vaccination ... of over $180 billion, even without including the large, intangible ... to retrospectively demonstrate the enormous benefits of polio vaccination appears ... December 2006 issue of Risk Analysis. , The history of ...
Cached Biology News:Leukemic cells find safe haven in bone marrow 2Leukemic cells find safe haven in bone marrow 3Microfluidic chip helps solve cellular mating puzzle 2Microfluidic chip helps solve cellular mating puzzle 3Billions of dollars saved in US by polio vaccination 2
Reacts with the 80 kDa fragment of the M-chain of human merosin....
Goat polyclonal to Rabenosyn 5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: ELKHTLAKQKGGTD, corresponding to C terminal amino acids 771-784 of Human Rabenosyn 5. Entr...
Acetyl CoA Carboxylase Antibody...
Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...
Biology Products: